Skip to main content
. 2025 Jan 11;59:111290. doi: 10.1016/j.dib.2025.111290

Table 4.

Interacting amino acids of the Human Maltase Gluco-amylase (2QMJ) with the ligands derived from Little Millet.

Ligands Hydrogen Bonds Alkyl and Pi bonds Attractive Charges Unfavourable bonds
Actinobolin Conventional HB: 3;
Arg471(1.98), Ser40(2.78), Thr196(2.98)
Alkyl: 1; Val244(4.11)
Pi-Alkyl: 1; Trp194(4.98)
Xanthosine Conventional HB: 2; Asp759(1.97), Glu760(2.69)
Carbon HB: 3;
Ala764(2.56), Gly731(2.62), Glu760(2.52)
Pi-alkyl: 1; Lys765(4.78) Unfavourable Donor-Donor: 1; Val699(1.96)
Arbutin Conventional HB: 2; Arg647(2.78), Glu767(2.19)
Carbon HB: 2;
Asp649(2.56), Pro736(3.01)
Pi-Pi T shaped: 1; Tyr636(4.97)
Pi-Anion:1;
Glu767(4.00)
Unfavourable Donor-Donor: 1; Arg653(1.28)
Sinapic acid Conventional HB: 5; Arg252(2.68),
Arg10(2.82),
Arg398(2.84),
Ser289(3.07),
Thr6(2.53)
Attractive charge: 1; Arg520(4.49) Unfavourable Negative- Negative: 1;
Asp402(5.26)
Caffeic acid Conventional HB: 1; Arg520(2.70)
Carbon HB: 1; Asp777(2.88)
Pi-Alkyl: 3; Ala285(3.43), Arg520(5.11)
Pi-Cation: 1; Lys776(4.28)
Tyrosine Conventional HB: 2; Arg647(2.71), Glu767(1.97)
Carbon HB: 1; Pro767(2.65)
Pi-Pi T shaped: 1; Tyr636(4.94)
Pi-Anion: 1; Glu767(4.05)
Salt Bridge Attractive Charge: 4; Arg653(2.43), Arg653(1.87),
Glu767(2.70), Glu767(2.52)
Attractive Charge: 2; Arg647(4.10), Asp649(5.03)
Unfavourable Donor-Donor: 1;
Arg647(1.80)
Unfavourable Acceptor-Acceptor: 1;
Ile734()
Maltose Conventional HB: 6;
Ile734(5.63),
Arg647(6.41),
Asp649(5.27), Glu658(5.02),
Glu658(5.38), Tyr733(6.42)
Carbon HB: 3;
Glu767(3.18),
Lys766(3.69)
Lys765(5.40)
Unfavourable Donor-Donor: 1; Arg653(6.34)
4-Fluoro-3-[1‑hydroxy-2-(methylamino)ethyl] phenol Conventional HB: 3; Arg520(2.54), Arg520(2.34), Arg520(2.03),
Carbon HB: 3; Ser521(2.95), Phe535(2.42), Phe535(2.77)
Pi-Alkyl: 3; Ala285(4.32), Ala537(4.56), Pro287(5.21)
Pi-Sulfur: 1; Met567(4.64)
Unfavourable Positive-Positive: 1; Lys776(5.15)
p-hydroxynorephedrine Conventional HB: 1; Ile734(2.17), Alkyl: Pro676(4.00)
Pi-Anion: 1; Glu767(3.85)
Pi-Pi T shaped: 1; Tyr636(5.03)
Unfavourable Donor-Donor: 1; Arg647(1.26)
Cathine Conventional HB: 1;
Arg520 (2.70)
Carbon HB: 1;
Asp777(2.88)
Alkyl: 1; Ala285(3.73)
Pi-Alkyl: 3; Arg520 (5.10),
Ala285(3.43)
Lys776(4.69)
Pi-Cation: 1;
Lys776(4.22)
L-Histidine Conventional HB: 4;
Asn543(4.13), His183(6.20),
Trp552(4.46),
Asp549(2.98)
Carbon HB: 1;
Ser553(4.17)
Pi-alkyl: 1;
Leu540(5.60)
Pi-sigma:1;
Val184(3.85)
Attractive charge: 1;
Asp549(3.75)
Unfavorable Negative-Negative: 1; Asp549(5.98)
Gluconic acid Conventional HB: 3;
Gln92(2.33), Phe119(2.02),
Gln117(2.45)
Carbon HB: 1;
His98(2.83),
Asp261(2.61)
Pi-Anion: 1;
His98(3.41)
L-Tryptophan Conventional HB: 1; Arg653(2.27) Pi-Alkyl: 2; Pro676(4.43), Pro676(4.86)
Pi-Anion: 1; Glu767(3.50)
Attractive charge: 2; Arg647(2.96), Arg653(4.88)
Salt- Bridge Attractive charge: 1; Glu658(3.01)
L-phenylephrine Conventional HB: 4; Arg526(2.39), Asp542(2.16), Asp542(2.65), His600(2.36), Pi-Anion: 1; Asp443(3.84)
Synephrine Conventional HB: 3;
Glu767(2.00), Glu767(2.06), Glu767(2.50)
Pi-Anion: 1;
Glu767(3.86)
Pyrido[3,4-d] imidazole, 1,6-dicarboxylic acid Conventional HB: 4; Ser395(2.68), Ser395(2.20), Asp396(2.57), Ser459(2.07)
Carbon HB: 1; Cys458(2.84)
Pi-Alkyl: 1; Leu401(5.46)
2,5-Dimethoxy-4-ethylamphetamine Carbon HB: 6;
Gly753(2.64), Leu754(2.59),
Glu815(2.72), Glu815(2.56),
Thr632(2.75), Glu815(4.10)
Alkyl: 4;
Ile755(4.88), Lys817(4.63),
Pro740(4.50), Tyr703(4.94)
Pi-Anion: 1;
Ile755(5.47)
1,2 O-Isopropylidene-alpha-d- glucofuranose Conventional HB: 4; Asn14(2.39), Asn14(2.52),
Ile16(2.57),
Val41(2.07)
Carbon HB: 1; Asn14(2.84)
Alkyl: 2;
Pro42(3.82),
Val244(4.93)
Pi-Alkyl: 1; Trp194(4.69)
Prosta 5,13‑dien-1-oic acid Alkyl: 1; Ala576(4.46)
Pi-Alkyl:7; Tyr299(5.12), Tyr299(5.11), Trp406(5.14),
Trp406(5.43), Phe575(4.88), Phe575(4.91), Phe575(5.43)
3-Ethoxy-4-hydroxymandelic acid Conventional HB: 3; Thr737(2.11), Gln739(2.71),
Glu815(2.85)
Carbon HB: 2; Gln738(2.99), Gly753(2.81)
Pi-Anion: 1; Glu815(3.23)
I-Guanidinosuccinimide Conventional HB: 3;
Phe535(2.28), Arg520(2.03),
Ser521(2.87)
Carbon HB: 1; Ala536(2.99),
D-Fructopyranose Conventional HB: 3; Leu752(1.97), Asn814(2.32), Asn814(2.20)
Carbon HB: 2; Gln738(2.96), Glu815(3.07)
Gulonic acid Conventional HB: 6;
Glu333(2.74),
Arg334(2.35), Asp329(2.72), Asp343(1.80), Glu300(2.45), Gly302(3.06)
Carbon HB:2; Gly302(3.06), Glu300(2.81)
Attractive charge: 1; Arg334(4.69) Unfavourable Donor-Donor: 1;
Glu333(1.25)
Unfavourable Negative- Negative: 1; Glu333(4.86)
Unfavourable Acceptor- Acceptor: 1;
Asp343(2.82)
5-(2-Aminopropyl)−2-methylphenol Conventional HB: 1; Asp348(2.47) Pi-Alkyl: 2; Lys519(5.26), His432(4.50)
Pi-Cation: 1; Phe516(4.14)
Pi - Pi T shaped: 1; Phe516(4.75)
Attractive charge: 1; Asp348(4.28)
Phe516()
Unfavourable Donor-Donor: 1; Ser521(2.32)
11-Eicosenoic acid Conventional HB: 1;
Gln603(2.05)
Carbon HB: 1;
Gly602(2.72)
Pi-alkyl: 10;
Tyr299(5.00),
Tyr299(4.21),
Trp406(4.66),
Trp406(5.45),
Trp406(4.96),
Trp406(4.69),
Phe450(5.41),
Phe450(4.32),
Phe450(4.96),
Phe575(4.87)
Mannoic acid Conventional HB: 4;
Ser456(3.05), Ser395(2.49),
Sr459(2.22), Asp485(2.79)
Carbon HB: 3; Cys458(2.66), Ser454(2.71), Ser456(2.65)
Unfavorable Negative-Negative: 1; Asp485(4.56)
Unfavorable Acceptor-Acceptor: 1; Ser394(2.82)
2- Butendioic acid Conventional HB: 2;
Phe535(6.41),
Ile523(3.68)
Carbon HB: 1;
Pro287(3.81)
Heptanedioic acid Conventional HB: 3;
Asn14(2.55), Arg254(2.25),
Asn14(2.11)
Carbon HB: 1; Pro17(2.92)
Alkyl: 1;
Pro42(4.63)
Pi-Anion: 1;
Trp43(4.89)
Attractive charge: 2; Arg254(3.97)
Arg471(3.18)
L- Alanine
ethylamide (S)
Conventional HB: 2;
Thr821(3.46),
Thr821 (3.61)
Alkyl: 4;
Lys762(4.22),
Leu758(4.90),
Lys762(5.09),
Val791(4.94)
Pi-alkyl: 3;
Trp868(5.22),
Trp868(4.94),
His870(3.99)
10-Octadecenoic acid Conventional HB: 2;
Trp43(4.84),
Ser40(4.14)
Alkyl: 4;
Pro21(4.89),
Pro21(5.14),
Pro42(4.89),
Val244(4.79)
Pi-Alkyl: 1;
Trp194(5.13)
Pi-Sigma: 1;
Trp43(2.46)
2-Propenoic acid,
n-pentadecyl ester
Alkyl: 1;
Leu127(4.80)
Pi-alkyl: 3;
Tyr91(5.23),
Phe65(5.10),
Phe65(4.56)